SE8901715L - En plasmid dna-konstruktion innehaallande dna-sekvenser - Google Patents

En plasmid dna-konstruktion innehaallande dna-sekvenser

Info

Publication number
SE8901715L
SE8901715L SE8901715A SE8901715A SE8901715L SE 8901715 L SE8901715 L SE 8901715L SE 8901715 A SE8901715 A SE 8901715A SE 8901715 A SE8901715 A SE 8901715A SE 8901715 L SE8901715 L SE 8901715L
Authority
SE
Sweden
Prior art keywords
dna sequences
plasmid
construction containing
dna
beta
Prior art date
Application number
SE8901715A
Other languages
Unknown language ( )
English (en)
Inventor
L Olsson
Original Assignee
Lope Medicine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lope Medicine Ab filed Critical Lope Medicine Ab
Priority to SE8901715A priority Critical patent/SE8901715L/sv
Priority to PCT/SE1990/000301 priority patent/WO1990013650A1/en
Priority to AU56741/90A priority patent/AU5674190A/en
Priority to EP19900908705 priority patent/EP0471787A1/en
Priority to JP2508094A priority patent/JPH04506150A/ja
Publication of SE8901715L publication Critical patent/SE8901715L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8901715A 1989-05-12 1989-05-12 En plasmid dna-konstruktion innehaallande dna-sekvenser SE8901715L (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8901715A SE8901715L (sv) 1989-05-12 1989-05-12 En plasmid dna-konstruktion innehaallande dna-sekvenser
PCT/SE1990/000301 WO1990013650A1 (en) 1989-05-12 1990-05-08 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
AU56741/90A AU5674190A (en) 1989-05-12 1990-05-08 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
EP19900908705 EP0471787A1 (en) 1989-05-12 1990-05-08 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
JP2508094A JPH04506150A (ja) 1989-05-12 1990-05-08 プラスミドｄｎａ構築物およびその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901715A SE8901715L (sv) 1989-05-12 1989-05-12 En plasmid dna-konstruktion innehaallande dna-sekvenser

Publications (1)

Publication Number Publication Date
SE8901715L true SE8901715L (sv) 1990-11-13

Family

ID=20375943

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901715A SE8901715L (sv) 1989-05-12 1989-05-12 En plasmid dna-konstruktion innehaallande dna-sekvenser

Country Status (5)

Country Link
EP (1) EP0471787A1 (sv)
JP (1) JPH04506150A (sv)
AU (1) AU5674190A (sv)
SE (1) SE8901715L (sv)
WO (1) WO1990013650A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1500399A1 (en) * 2003-07-24 2005-01-26 Institut Pasteur Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat

Also Published As

Publication number Publication date
AU5674190A (en) 1990-11-29
EP0471787A1 (en) 1992-02-26
JPH04506150A (ja) 1992-10-29
WO1990013650A1 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
AU560340B2 (en) Rennin from recombinant dna
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
DK639689D0 (da) Indfoering af dna i celler
DK506488A (da) Fremgangsmaade til dyrkning af rekombinante celler, vaertscelle til anvendelse ved fremgangsmaaden og kultur omfattende vaertscellen
DE69635864D1 (de) Rekombinante rna-replikase von hepatitis-c-virus
ZA942778B (en) Recombinant viruses, and their preparation and use in gene therapy.
ES8800987A1 (es) Metodo de produccion del factor viii:c humano
ES2013324A6 (es) Un metodo mejorado para producir una proteina heterologa.
AU682140B2 (en) Multidrug resistance gene
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
ATE278024T1 (de) Methode zur herstellung von rekombinanten zellen
FI885679A (fi) Samuttryckning i eukariotiska celler.
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
ES8801376A1 (es) Un procedimiento para preparar una proteina hibrida
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
KR880700855A (ko) 진핵생물 단백질을 발현시키는 개선된 방법
GR3031229T3 (en) Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
SE8901715L (sv) En plasmid dna-konstruktion innehaallande dna-sekvenser
EP0282330A3 (en) Method for stimulating gene expression
AUPM772494A0 (en) Improvements in production of proteins in host cells
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
DE69923595D1 (de) Herstellung von proteinen
NO179453C (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin, vertscelle som produserer proteinet, rekombinant vektor inneholdt i vertscellen, samt nukleotidsekvens som koder for proteiner med amphiregulinaktivitet
JPS6485094A (en) Novel physiologically active polypeptide

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901715-6

Effective date: 19940818